Helping patients make informed choices about probiotics: a need for research
- PMID: 19343022
- PMCID: PMC2746707
- DOI: 10.1038/ajg.2008.68
Helping patients make informed choices about probiotics: a need for research
Abstract
Applications of probiotics in the treatment of gastrointestinal disorders are gaining acceptance among patients, despite evidence that probiotics can present substantial health risks, particularly for patients who are immunocompromised or seriously ill. Patients will likely formulate their attitudes and beliefs about probiotic therapies with reference to interpretive frameworks that compare probiotics with more familiar therapeutic modalities, including complementary and alternative medicines, pharmacological therapies, and gene-transfer technologies. Each of these frameworks highlights a different set of benefit-to-risk considerations regarding probiotic usage and reinforces extreme characterizations of both the therapeutic promise and peril of probiotics. Considerable effort may be required to help patients make informed choices about probiotic therapies.
Similar articles
-
An analysis of online messages about probiotics.BMC Gastroenterol. 2013 Jan 11;13:5. doi: 10.1186/1471-230X-13-5. BMC Gastroenterol. 2013. PMID: 23311418 Free PMC article.
-
Recent Advances in Probiotics as Live Biotherapeutics Against Gastrointestinal Diseases.Curr Pharm Des. 2018;24(27):3162-3171. doi: 10.2174/1381612824666180717105128. Curr Pharm Des. 2018. PMID: 30014799 Review.
-
When to use probiotics in luminal gastrointestinal disorders?Curr Opin Clin Nutr Metab Care. 2020 Sep;23(5):336-343. doi: 10.1097/MCO.0000000000000674. Curr Opin Clin Nutr Metab Care. 2020. PMID: 32657791 Review.
-
The therapeutic effect of probiotic bacteria on gastrointestinal diseases.Adv Clin Exp Med. 2013 Sep-Oct;22(5):759-66. Adv Clin Exp Med. 2013. PMID: 24285463 Review.
-
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4. Cochrane Database Syst Rev. 2017. PMID: 29257353 Free PMC article. Review.
Cited by
-
Who uses probiotics and why? A survey study conducted among general gastroenterology patients.BMJ Open Gastroenterol. 2021 Aug;8(1):e000742. doi: 10.1136/bmjgast-2021-000742. BMJ Open Gastroenterol. 2021. PMID: 34446439 Free PMC article.
-
Help, hope and hype: ethical considerations of human microbiome research and applications.Protein Cell. 2018 May;9(5):404-415. doi: 10.1007/s13238-018-0537-4. Protein Cell. 2018. PMID: 29675808 Free PMC article. No abstract available.
-
Maternal perspectives on the use of probiotics in infants: a cross-sectional survey.BMC Complement Altern Med. 2014 Sep 29;14:366. doi: 10.1186/1472-6882-14-366. BMC Complement Altern Med. 2014. PMID: 25267264 Free PMC article.
-
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.Aliment Pharmacol Ther. 2013 Oct;38(8):864-86. doi: 10.1111/apt.12460. Epub 2013 Aug 27. Aliment Pharmacol Ther. 2013. PMID: 23981066 Free PMC article. Review.
-
"Snake-oil," "quack medicine," and "industrially cultured organisms:" biovalue and the commercialization of human microbiome research.BMC Med Ethics. 2012 Oct 30;13:28. doi: 10.1186/1472-6939-13-28. BMC Med Ethics. 2012. PMID: 23110633 Free PMC article.
References
-
- Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512–9. - PubMed
-
- Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006;130(2 Suppl 1):S78–90. - PubMed
-
- Food and Agriculture Organization of the United Nations. World Health Organization Report on Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001. < ftp://ftp.fao.org/es/ esn/food/probio_report_en.pdf>. Accessed 7 February 2008.
-
- Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2005;22:365–72. - PubMed
-
- Pillai A, Nelson R. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev [online] 23 January 2008;CD004611 (doi:10.1002/14651858.CD004611.pub2). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
